Autros Acquisition, Guardian Software May Boost Baxter Public Safety Image
This article was originally published in The Gray Sheet
Recent patient safety-related measures taken by Baxter International may help improve the firm's public image after a series of recalls and warning letters related to Baxter dialyzers and infusion pumps
You may also be interested in...
Planned closure of the firm's Ronneby, Sweden and Miami Lakes, Florida plants, which made recently discontinued A-series hemodialyzer components, is announced Nov. 26. The Swedish filter plant and the Florida filter fiber facility employed 158 and 98 people, respectively. A small team will remain at both locations to continue ongoing investigations into more than 50 deaths worldwide that appear linked to a processing fluid residue ("The Gray Sheet" Nov. 12, 2001, p. 16). Baxter has agreed to pay the families of 10 fatalities in Spain $289,000 each under a settlement agreement; the families are asking the Spanish government to drop a planned lawsuit. A Swedish criminal investigation is ongoing...
Dispatches from a world turned upside down include FDA expressing confidence in Chinese manufacturers – to make their GDUFA payments; projections of drug shortages for ventilator patients; and the launch of new hydroxychloroquine studies.
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.